Brad Thatcher
23Patents
8h-index
7Co-inventors
64Inventor score
Filing activity: Apr 30, 2001 → Feb 10, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6890763B2 | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons | Emerging Cross-Sectional Technologies | 55 | Expired |
| US6602855B2 | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6617308B2 | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6620786B2 | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6627606B2 | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6593298B2 | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6620787B2 | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6703366B2 | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6627608B2 | Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6677303B2 | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6756476B2 | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6627607B2 | Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6599877B2 | Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7314717B2 | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7294688B2 | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons | Physics | 2 | Expired |
| US7049397B2 | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6998243B2 | Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7229638B2 | Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7087435B2 | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6693080B2 | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8263351B2 | Diagnostic methods for congestive heart failure | Physics | 0 | Active |
| US7008800B2 | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7125726B2 | Method and kit for diagnosing myocardial infarction | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.